A citation-based method for searching scientific literature

Mary B Daly, Robert Pilarski, Michael Berry, Saundra S Buys, Meagan Farmer, Susan Friedman, Judy E Garber, Noah D Kauff, Seema Khan, Catherine Klein, Wendy Kohlmann, Allison Kurian, Jennifer K Litton, Lisa Madlensky, Sofia D Merajver, Kenneth Offit, Tuya Pal, Gwen Reiser, Kristen Mahoney Shannon, Elizabeth Swisher, Shaveta Vinayak, Nicoleta C Voian, Jeffrey N Weitzel, Myra J Wick, Georgia L Wiesner, Mary Dwyer, Susan Darlow. J Natl Compr Canc Netw 2017
Times Cited: 287



Gaëlle Bougeard, Mariette Renaux-Petel, Jean-Michel Flaman, Camille Charbonnier, Pierre Fermey, Muriel Belotti, Marion Gauthier-Villars, Dominique Stoppa-Lyonnet, Emilie Consolino, Laurence Brugières, Olivier Caron, Patrick R Benusiglio, Brigitte Bressac-de Paillerets, Valérie Bonadona, Catherine Bonaïti-Pellié, Julie Tinat, Stéphanie Baert-Desurmont, Thierry Frebourg. J Clin Oncol 2015
Times Cited: 267




List of shared articles



Times cited

Targeted gene panels identify a high frequency of pathogenic germline variants in patients diagnosed with a hematological malignancy and at least one other independent cancer.
Deepak Singhal, Christopher N Hahn, Simone Feurstein, Li Yan A Wee, Luke Moma, Monika M Kutyna, Rakchha Chhetri, Leila Eshraghi, Andreas W Schreiber, Jinghua Feng,[...]. Leukemia 2021
3

One in three highly selected Greek patients with breast cancer carries a loss-of-function variant in a cancer susceptibility gene.
Florentia Fostira, Irene Kostantopoulou, Paraskevi Apostolou, Myrto S Papamentzelopoulou, Christos Papadimitriou, Eleni Faliakou, Christos Christodoulou, Ioannis Boukovinas, Evangelia Razis, Dimitrios Tryfonopoulos,[...]. J Med Genet 2020
9

Apparently Heterozygous TP53 Pathogenic Variants May Be Blood Limited in Patients Undergoing Hereditary Cancer Panel Testing.
Jessica L Mester, Sarah A Jackson, Kristen Postula, Amy Stettner, Sheila Solomon, Jeffrey Bissonnette, Patricia D Murphy, Rachel T Klein, Kathleen S Hruska. J Mol Diagn 2020
8

Differences in patient ascertainment affect the use of gene-specified ACMG/AMP phenotype-related variant classification criteria: Evidence for TP53.
Cristina Fortuno, Tina Pesaran, Jill Dolinsky, Amal Yussuf, Kelly McGoldrick, David Goldgar, Paul A James, Amanda B Spurdle. Hum Mutat 2020
1

Whole-body MRI within a surveillance program for carriers with clinically actionable germline TP53 variants - the Swedish constitutional TP53 study SWEP53.
Meis Omran, Lennart Blomqvist, Yvonne Brandberg, Niklas Pal, Per Kogner, Anne Kinhult Ståhlbom, Emma Tham, Svetlana Bajalica-Lagercrantz. Hered Cancer Clin Pract 2020
0

Genotype-phenotype correlations among TP53 carriers: Literature review and analysis of probands undergoing multi-gene panel testing and single-gene testing.
Cristina Fortuno, Tina Pesaran, Jessica Mester, Jill Dolinsky, Amal Yussuf, Kelly McGoldrick, Paul A James, Amanda B Spurdle. Cancer Genet 2020
0